Effects of a protective agent on freeze-dried platelet-rich plasma. 2019

Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
Department of Blood Transfusion, General Hospital of Southern Theatre Command of PLA.

: Freeze-drying is an effective means of storing platelets. In this study, we investigated the effects of a protective agent on freeze-dried platelet-rich plasma (FD-PRP) after a 12-week preservation period. Platelet structure was measured by transmission electron microscopy (TEM), and the expression levels of procaspase activating compound (PAC)-1 and CD62P were measured by flow cytometry. The levels of transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) were determined by ELISA. The effect of FD-PRP on cell proliferation was measured by cell counting. TEM revealed that most platelets were intact, and their internal structure was evident. The expression levels of the platelet activation marker CD62P in FD-PRP and fresh PRP were 36.83% ± 8.21 and 35.47% ± 4.11, respectively, without a significant difference (P > 0.05). The expression levels of PAC-1 in FD-PRP and fresh PRP were 3.23% ± 0.49 and 2.83% ± 0.44, respectively, without a significant difference (P > 0.05). Upon activation of FD-PRP and fresh PRP by thrombin, the levels of TGF-β, PDGF and VEGF were not significantly decreased in FD-PRP. Moreover, FD-PRP promoted cell proliferation in a manner similar to that of fresh PRP. The protective agent maintained the biological activity of FD-PRP after a 12-week preservation period.

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D005612 Freeze Drying Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products. Lyophilization,Drying, Freeze,Dryings, Freeze,Freeze Dryings,Lyophilizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D053657 Platelet-Rich Plasma A preparation consisting of PLATELETS concentrated in a limited volume of PLASMA. This is used in various surgical tissue regeneration procedures where the GROWTH FACTORS in the platelets enhance wound healing and regeneration. Plasma, Platelet-Rich,Platelet Rich Plasma
D019007 P-Selectin Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells. Antigens, CD62P,CD62P Antigens,GMP-140,LECAM-3,P Selectin,Platelet alpha-Granule Membrane Protein,CD62P Antigen,PADGEM,Antigen, CD62P,Platelet alpha Granule Membrane Protein,Selectin, P

Related Publications

Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
January 2017, Archives of oral biology,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
January 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
January 2012, Platelets,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
March 2007, Clinical oral investigations,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
January 2020, Asian spine journal,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
June 2019, Regenerative medicine,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
July 2019, The American journal of sports medicine,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
November 2018, ACS biomaterials science & engineering,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
February 2023, Journal of equine veterinary science,
Linying Shi, and Rongjuan Li, and Shuzhen Wei, and Mou Zhou, and Lei Li, and Fang Lin, and Yanhui Li, and Zixuan Guo, and Wei Zhang, and Mingliang Chen, and Guiqiu Shan
January 2016, Eplasty,
Copied contents to your clipboard!